Quick Answer
HOOKIPA Pharma Inc. reported Earnings Per Share Diluted of $3.47 (loss) per share for the year ending 2024.
- HOOKIPA Pharma Inc. showed an increase of +59.8% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2019 to 2024), HOOKIPA Pharma Inc.'s Earnings Per Share Diluted has declined by 44.0%.
- Historical annual values: Fiscal year 2024: $3.47 (loss) per share | Fiscal year 2023: $8.63 (loss) per share | Fiscal year 2022: $9.91 (loss) per share | Fiscal year 2021: $2.30 (loss) per share | Fiscal year 2020: $1.69 (loss) per share | Fiscal year 2019: $2.41 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: